Germany Asks Cos. To Look For Tainted Heparin

Law360, New York (March 13, 2008, 12:00 AM EDT) -- Germany's drug safety regulator ordered companies in the country on Wednesday to test their stocks of heparin, a blood thinner at the center of an international recall, for any signs of contamination.

Last week, Rotexmedica GmbH, a unit of Groupe Panpharma, recalled three batches of heparin in Germany after 80 dialysis patients who took the drug experienced allergic reactions to it.

On Wednesday, the Federal Institute for Drugs and Medical Devices asked 10 heparin manufacturers to carry out additional tests and hopes to get results soon....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.